Capsida Logo
  • About
    • Overview
    • Leadership Team
    • Board of Directors
    • Investors
    • History
    • Contact
  • Innovation
    • Capsida Approach
    • Capsid Engineering
    • Discovery & Preclinical
    • GMP Manufacturing Operations
    • Clinical Development
  • Pipeline
    • Overview
    • CAP-002: STXBP1
    • CAP-003: GBA
    • CAP-004: FA
  • Patients
    • Overview
    • STXBP1 Developmental and Epileptic Encephalopathy
    • Reece’s Story
    • Parkinson’s Disease Associated with GBA Mutations
    • Friedreich’s Ataxia
  • Partnering
    • Opportunities to Partner
    • Strategic Collaborations
    • Industry Associations
  • News
    • Press Releases
    • Publications
    • Presentations
  • Careers
    • Culture & Benefits
    • Current Opportunities

Home

© 2025 Capsida Biotherapeutics. All rights reserved – Privacy Policy | Terms of Use

Privacy Preference Center

Privacy Preferences